The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1379
ISSUE1379
December 12, 2011
Safety of Dronedarone (Multaq)
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Safety of Dronedarone (Multaq)
December 12, 2011 (Issue: 1379)
Dronedarone (Multaq – Sanofi), an analog of amiodarone,
was approved by the FDA in 2009 for oral treatment
of paroxysmal or persistent (non-permanent) atrial
fibrillation or atrial flutter. Amiodarone (Cordarone, and
others) is more effective...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.